Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Taminau

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMC Cancer|June 19, 2019
A new mouse model to study the role of ectopic Nanos3 expression in cancerVanessa Andries, Evi De Keuckelaere, Katrien Staes, et al.
Molecular Oncology|June 18, 2025
EMT-associated bias in the Parsortix® system observed with pancreatic cancer cell linesNele Vandenbussche, Renske Imschoot, Béatrice Lintermans, et al.
Epigenetics & Chromatin|November 18, 2018
ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transitionNicolas Skrypek, Kenneth Bruneel, Cindy Vandewalle, et al.
Cellular and Molecular Life Sciences : CMLS|February 28, 2014
ZEB2-transgene expression in the epidermis compromises the integrity of the epidermal barrier through the repression of different tight junction proteinsMarianthi N Tatari, Bram De Craene, Bieke Soen, et al.
Scientific Reports|April 23, 2020
Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinomaElien De Thaye, Koen Van de Vijver, Joni Van der Meulen, et al.
The Journal of Experimental Medicine|May 18, 2016
The transcription factor Zeb2 regulates development of conventional and plasmacytoid DCs by repressing Id2Charlotte L Scott, Bieke Soen, Liesbet Martens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2020
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor ProtectionTania Løve Aaes, Hanne Verschuere, Agnieszka Kaczmarek, et al.
Iscience|November 18, 2024
ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition statesJeroen Verstappe, Nicolas Skrypek, Jordy De Coninck, et al.
Science Advances|November 1, 2024
A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemiaLisa Demoen, Filip Matthijssens, Lindy Reunes, et al.
Cell Reports|April 7, 2016
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor ImmunityTania Løve Aaes, Agnieszka Kaczmarek, Tinneke Delvaeye, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMC Cancer|June 19, 2019
A new mouse model to study the role of ectopic Nanos3 expression in cancerVanessa Andries, Evi De Keuckelaere, Katrien Staes, et al.
Molecular Oncology|June 18, 2025
EMT-associated bias in the Parsortix® system observed with pancreatic cancer cell linesNele Vandenbussche, Renske Imschoot, Béatrice Lintermans, et al.
Epigenetics & Chromatin|November 18, 2018
ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transitionNicolas Skrypek, Kenneth Bruneel, Cindy Vandewalle, et al.
Cellular and Molecular Life Sciences : CMLS|February 28, 2014
ZEB2-transgene expression in the epidermis compromises the integrity of the epidermal barrier through the repression of different tight junction proteinsMarianthi N Tatari, Bram De Craene, Bieke Soen, et al.
Scientific Reports|April 23, 2020
Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinomaElien De Thaye, Koen Van de Vijver, Joni Van der Meulen, et al.
The Journal of Experimental Medicine|May 18, 2016
The transcription factor Zeb2 regulates development of conventional and plasmacytoid DCs by repressing Id2Charlotte L Scott, Bieke Soen, Liesbet Martens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2020
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor ProtectionTania Løve Aaes, Hanne Verschuere, Agnieszka Kaczmarek, et al.
Iscience|November 18, 2024
ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition statesJeroen Verstappe, Nicolas Skrypek, Jordy De Coninck, et al.
Science Advances|November 1, 2024
A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemiaLisa Demoen, Filip Matthijssens, Lindy Reunes, et al.
Cell Reports|April 7, 2016
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor ImmunityTania Løve Aaes, Agnieszka Kaczmarek, Tinneke Delvaeye, et al.
Pageof 2